investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Metabolic pathways in leukemia
John D Schuetz
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
John D Schuetz
St. Jude Children's Research Hospital
Memphis, United States
Related projects
Catherine Ju-Ying Wu
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
Leukaemia
Tait D Shanafelt
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Benjamin Levine Ebert
Development of Novel Therapeutic Strategies in Human Leukemias
Leukaemia
David Marc Weinstock
Polysomy 21 in Acute Lymphoblastic Leukemia
Leukaemia
Mary Ellen Conley
Genetic Etiology of Agammaglobulinemia with Absent B Cells
Leukaemia
Alan B. Cantor
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Bruce R Blazar
Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)
Leukaemia
Pathology
Hematology and hematologic malignancies
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
Margaret A Goodell
Regulation of Hematopoietic Progenitors by de novo DNA Methylation
Leukaemia